| Dr Edwin G Bovill, MD | |
|
111 Colchester Ave, Fletcher Allen Health Care, Pathology, Burlington, VT 05401-1473 | |
| (802) 656-0359 | |
| (802) 656-8892 |
| Full Name | Dr Edwin G Bovill |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184640377 | NPI | - | NPPES |
| 00789859 | Medicaid | NY | |
| 00789859 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 042-0006429 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edwin G Bovill, MD 414 Clearwater Rd, Shelburne, VT 05482-7725 Ph: (802) 985-8257 | Dr Edwin G Bovill, MD 111 Colchester Ave, Fletcher Allen Health Care, Pathology, Burlington, VT 05401-1473 Ph: (802) 656-0359 |
News Archive
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
The latest success of Martek Biosciences, a rising-star among Maryland biotechs, began more than a decade ago in a plain, brick building on the University of Maryland campus. With a good idea and early-stage nurturing from the university's Maryland Technology Enterprise Institute (Mtech), the company has been able to grow into a major international business.
S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.
Cyberonics, Inc. has announced that study sites are being recruited for two new Phase IV epilepsy studies and that three epilepsy educational symposia have been scheduled.
› Verified 7 days ago
Dr. Laura Aman Greene, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Ep-2-113, Burlington, VT 05401 Phone: 802-847-3566 Fax: 802-847-4155 | |
Dr. Pamela Cox Gibson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-3989 Fax: 802-847-9644 | |
Dr. Mark K Fung, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care - Pathology, Burlington, VT 05401 Phone: 802-847-3000 Fax: 802-847-3509 | |
Dr. Nicholas Jackson Hardin, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2795 Fax: 802-847-9644 | |
Dr. Siba El Hussein, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-5121 | |
Ms. Allison Leigh Ciolino, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-5121 | |
Dr. John H Lunde, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Pathology, Burlington, VT 05401 Phone: 802-847-5135 Fax: 802-847-3987 |